Sintilimab plus anlotinib as first-line therapy in patients (pts) with advanced hepatocellular carcinoma (aHCC)

Chen, X; Li, W; Wu, X; Zhao, F; Wu, H; Gu, Y; Li, X; Qian, X; Hu, J; Li, C; Xia, Y; Yao, A; Seesaha, PK; Shao, Q; Dong, X; Li, X; Shu, Y

ANNALS OF ONCOLOGY, 2020; 31 (): S1305

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索